Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blastomycosis.

R W Bradsher1

  • 1Department of Medicine, University of Arkansas for Medical Sciences, Little Rock 72205.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Blastomycosis, a fungal infection common in the midwestern US, often presents as pneumonia. For non-life-threatening cases, oral antifungals like ketoconazole are recommended over Amphotericin B.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Oculoglandular tularemia.

Archives of ophthalmology (Chicago, Ill. : 1960)·1999
Same author

Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1998
Same author

Clinical features of blastomycosis.

Seminars in respiratory infections·1997
Same author

Therapy of blastomycosis.

Seminars in respiratory infections·1997
Same author

Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1997
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Area of Science:

  • Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Blastomycosis is a rare but significant fungal infection endemic to the south central and midwestern United States.
  • Pneumonia is the most common initial manifestation, with lungs being the primary site of infection.
  • Other commonly affected organs include skin, bone, prostate, and the central nervous system.

Purpose of the Study:

  • To review the epidemiology and clinical manifestations of blastomycosis.
  • To evaluate current and emerging therapeutic options for blastomycosis.
  • To provide guidance on treatment selection based on disease severity and location.

Main Methods:

  • Literature review of epidemiological data and clinical case studies.
  • Analysis of treatment outcomes for various antifungal agents.

Related Experiment Videos

  • Comparison of efficacy and toxicity profiles of Amphotericin B, ketoconazole, itraconazole, and fluconazole.

    • Main Results:

    • Amphotericin B is effective but toxic; oral agents are preferred for non-life-threatening disease.
    • Ketoconazole is recommended as a replacement for Amphotericin B in non-life-threatening blastomycosis.
    • Itraconazole shows promise as an effective alternative, while fluconazole's utility remains unproven.

    Conclusions:

    • Treatment decisions for blastomycosis should consider disease severity and organ involvement.
    • For non-life-threatening blastomycosis, oral antifungals offer a viable alternative to Amphotericin B.
    • Amphotericin B remains the gold standard for severe or central nervous system blastomycosis.